Publicaciones en colaboración con investigadores/as de Harvard Medical School (21)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Characterization of Ly108-H1 Signaling Reveals Ly108-3 Expression and Additional Strain-Specific Differences in Lupus Prone Mice

    International Journal of Molecular Sciences, Vol. 24, Núm. 5

  3. Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1

    Journal of Immunology, Vol. 210, Núm. 6, pp. 709-720

2022

  1. Editorial: Engineered immune cells in cancer immunotherapy (EICCI)

    Frontiers in Immunology

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. SLAMF8 Downregulates Mouse Macrophage Microbicidal Mechanisms via PI3K Pathways

    Frontiers in Immunology, Vol. 13

2020

  1. Intracolonic Mustard Oil Induces Visceral Pain in Mice by TRPA1-Dependent and -Independent Mechanisms: Role of Tissue Injury and P2X Receptors

    Frontiers in Pharmacology, Vol. 11

  2. Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar

    Frontiers in Immunology, Vol. 11

2015

  1. Expression inactivation of SMARCA4 by microRNAs in lung tumors

    Human Molecular Genetics, Vol. 24, Núm. 5, pp. 1400-1409

2012

  1. Cutting edge: Slamf8 is a negative regulator of Nox2 activity in macrophages

    Journal of Immunology, Vol. 188, Núm. 12, pp. 5829-5832

2011

  1. A novel isoform of the Ly108 gene ameliorates murine lupus

    Journal of Experimental Medicine, Vol. 208, Núm. 4, pp. 811-822

2006

  1. CD48 Controls T-Cell and Antigen-Presenting Cell Functions in Experimental Colitis

    Gastroenterology, Vol. 130, Núm. 2, pp. 424-434

2005

  1. Defective B cell responses in the absence of SH2D1A

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Núm. 13, pp. 4819-4823

2004

  1. Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression

    Journal of Immunology, Vol. 172, Núm. 10, pp. 5823-5827

2002

  1. Phosphorylation of the N-terminal and C-terminal CD3-ε-ITAM tyrosines is differentially regulated in T cells

    Biochemical and Biophysical Research Communications, Vol. 291, Núm. 3, pp. 574-581

1999

  1. The CD3-γδε transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells

    Journal of Biological Chemistry, Vol. 274, Núm. 29, pp. 20633-20642

1998

  1. CD38 is functionally dependent on the TCR/CD3 complex in human T cells

    FASEB Journal, Vol. 12, Núm. 7, pp. 581-592

1996

  1. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients

    Clinical and Experimental Immunology, Vol. 104, Núm. 1, pp. 72-79

1994

  1. GO, a guanine nucleotide binding protein, is expressed during neurite extension in the embryonic mouse

    Journal of Neuroscience Research, Vol. 38, Núm. 2, pp. 182-187

1992

  1. T cell lines characterize events in the pathogenesis of the wiskott-aldrich syndrome

    Journal of Experimental Medicine, Vol. 176, Núm. 3, pp. 867-874